Cefazolin and Impetigo - a phase IV clinical study of FDA data

Summary:

Impetigo is reported as a side effect among people who take Cefazolin (cefazolin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Opdivo, and have Brain oedema.

The phase IV clinical study analyzes which people have Impetigo when taking Cefazolin. It is created by eHealthMe based on reports of 15,127 people who have side effects when taking Cefazolin from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Impetigo?

Impetigo (contagious skin infection) is found to be associated with 333 drugs and 453 conditions by eHealthMe. Check the latest studies of Impetigo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

15,127 people reported to have side effects when taking Cefazolin.
Among them, 13 people (0.09%) have Impetigo.

Among these 13 people:

How long have people been on Cefazolin when they have Impetigo? *

What is the gender of people who have Impetigo when taking Cefazolin? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Impetigo when taking Cefazolin? *

What are other drugs people take besides Cefazolin? *

What are other side effects people have besides Impetigo? *

Malaise (a feeling of general discomfort or uneasiness): 7 people, 53.85%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 53.85%
Hepatic Function Abnormal: 7 people, 53.85%
Fever: 7 people, 53.85%
Hyperthyroidism (over activity of the thyroid gland): 7 people, 53.85%
Secondary Adrenocortical Insufficiency (inadequate secretion of acth by the pituitary gland): 7 people, 53.85%
Postoperative Wound Infection: 7 people, 53.85%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 7 people, 53.85%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 7 people, 53.85%
Renal Impairment (severely reduced kidney function): 7 people, 53.85%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 7 people, 53.85%
Metastases To Central Nervous System (cancer spreads to central nervous system): 7 people, 53.85%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 7 people, 53.85%
Breast Cancer Metastatic: 4 people, 30.77%
Wound Infection: 1 person, 7.69%
Parkinson's Disease: 1 person, 7.69%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and have Impetigo?

- Check whether Impetigo is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin:

Cefazolin (15,157 reports)

Impetigo treatments and more:

Impetigo (2,385 reports)

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impetigo:

Impetigo (333 drugs)

Browse all the conditions that are associated with Impetigo:

Impetigo (453 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin) and Cefazolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.